Evidence map›Paper›PMID 35983065›Full record

ReviewFrontiers in immunology2022

Signaling networks controlling ID and E protein activity in T cell differentiation and function.

Sung-Min Hwang, Sin-Hyeog Im, Dipayan Rudra

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07413263 (Impact of Tyrosine Kinase Inhibitors on Glucose and Lipid Metabolism in Chronic Myeloid Leukemia), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07413263 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Impact of Tyrosine Kinase Inhibitors on Glucose and Lipid Metabolism in Chronic Myeloid Leukemia

TypeobservationalSponsorAssiut UniversityRan2026 to 2028Enrolled75ConditionsChronic Myeloid LeukemiaArmsTyrosine kinase Inhibitors (Imatinib & Nilotinib)
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Exosome Proteomics of SOD1Annals of clinical and translational neurology · 2026
    Article
  3. Article
  4. Article
  5. HEB Restrains Effector Gene Expression during Early CD8Molecular and cellular biology · 2025
    Article
  6. Principles of Computation by Competitive Protein Dimerization Networks.bioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Sung-Min HwangDepartment of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY, United States.
Sin-Hyeog ImDepartment of Life Sciences, Pohang University of Science and Technology, Pohang, South Korea.
Dipayan RudraSchool of Life Science and Technology, ShanghaiTech University, Shanghai, China.
Cornell University · USShanghaiTech University · CNYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

E and inhibitor of DNA binding (ID) proteins are involved in various cellular developmental processes and effector activities in T cells. Recent findings indicate that E and ID proteins are not only responsible for regulating thymic T cell development but also modulate the differentiation, function, and fate of peripheral T cells in multiple immune compartments. Based on the well-established E and ID protein axis (E-ID axis), it has been recognized that ID proteins interfere with the dimerization of E proteins, thus restricting their transcriptional activities. Given this close molecular relationship, the extent of expression or stability of these two protein families can dynamically affect the expression of specific target genes involved in multiple aspects of T cell biology. Therefore, it is essential to understand the endogenous proteins or extrinsic signaling pathways that can influence the dynamics of the E-ID axis in a cell-specific and context-dependent manner. Here, we provide an overview of E and ID proteins and the functional outcomes of the E-ID axis in the activation and function of multiple peripheral T cell subsets, including effector and memory T cell populations. Further, we review the mechanisms by which endogenous proteins and signaling pathways alter the E-ID axis in various T cell subsets influencing T cell function and fate at steady-state and in pathological settings. A comprehensive understanding of the functions of E and ID proteins in T cell biology can be instrumental in T cell-specific targeting of the E-ID axis to develop novel therapeutic modalities in the context of autoimmunity and cancer.

Indexed as

Lymphocyte ActivationTranscription FactorsCell DifferentiationSignal TransductionT-Lymphocyte SubsetsTranscription FactorsE-ID axisE proteinsID proteinsregulatory T (Treg) cellssignaling pathwaysT cell differentiationT cell function

Identifiers

PMID35983065
PMCPMC9379924
OpenAlexW4289520522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.